Literature DB >> 15910863

Plasma metabolism of apoB-containing lipoproteins in patients with hepatic lipase deficiency.

Isabelle L Ruel1, Patrick Couture, Jeffrey S Cohn, Benoît Lamarche.   

Abstract

The metabolism of apoB-containing lipoproteins was investigated in the fasted state in three complete and three partial hepatic lipase (HL)-deficient subjects as well as in seven normotriglyceridemic (NTG) and two hypertriglyceridemic (HTG) controls using a 12 h primed-constant infusion of L-[5,5,5-D(3)]-leucine. Two males with complete HL deficiency had increased plasma pool sizes of VLDL and IDL apoB-100 due to substantial reductions in fractional catabolic rate (FCR) of VLDL and IDL apoB-100 compared with both NTG and HTG controls. Reductions in LDL apoB-100 production rate (PR) were also observed in these two patients compared with NTG and HTG controls. Complete HL deficiency in the female proband was associated with normal VLDL apoB-100 kinetics, while plasma IDL apoB-100 pool size was increased by 124% due to an 82% decrease in the FCR of IDL apoB-100. The FCR and PR of LDL apoB-100 were reduced by 64 and 51%, respectively, in the proband compared with sex-matched controls. Partial HL-deficient patients were characterized by apoB-containing lipoprotein metabolism similar to that of controls. These results indicate that complete HL deficiency is associated with a potentially atherogenic apoB-containing lipoprotein metabolism that can be modulated considerably by secondary factors such as gender and abdominal obesity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15910863     DOI: 10.1016/j.atherosclerosis.2004.12.014

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Secretion of triacylglycerol-poor VLDL particles from McA-RH7777 cells expressing human hepatic lipase.

Authors:  Michelle Bamji-Mirza; Meenakshi Sundaram; Shumei Zhong; Erik F Yao; Robin J Parks; Zemin Yao
Journal:  J Lipid Res       Date:  2010-12-27       Impact factor: 5.922

Review 2.  Treatment of dyslipidemia in children and adolescents.

Authors:  Kathryn Wood Holmes; Peter Oscar Kwiterovich
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

3.  Diagnostic markers based on a computational model of lipoprotein metabolism.

Authors:  Daniël B van Schalkwijk; Ben van Ommen; Andreas P Freidig; Jan van der Greef; Albert A de Graaf
Journal:  J Clin Bioinforma       Date:  2011-10-26

Review 4.  Causes and Consequences of Hypertriglyceridemia.

Authors:  Chris J Packard; Jan Boren; Marja-Riitta Taskinen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-14       Impact factor: 5.555

5.  Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease.

Authors:  Hui Han; Daopeng Dai; Wencheng Wang; Jinzhou Zhu; Zhengbin Zhu; Lin Lu; Ruiyan Zhang
Journal:  J Interv Med       Date:  2019-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.